Jpmorgan Chase & CO Personalis, Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Personalis, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 4,870 shares of PSNL stock, worth $46,849. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,870
Previous 5,854
16.81%
Holding current value
$46,849
Previous $33,000
48.48%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding PSNL
# of Institutions
112Shares Held
36.6MCall Options Held
82.9KPut Options Held
74.1K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.11MShares$68.4 Million0.39% of portfolio
-
Aigh Capital Management LLC Baltimore, MD3.72MShares$35.8 Million13.81% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$31.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.14MShares$30.2 Million0.0% of portfolio
-
Abrdn PLC1.76MShares$16.9 Million0.02% of portfolio
About Personalis, Inc.
- Ticker PSNL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 45,918,400
- Market Cap $442M
- Description
- Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...